Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Oncology Therapeutic Drug Market Growth 2022-2028

  • LP 4970710
  • 127 Pages
  • July 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Oncology Therapeutic Drug will have significant change from previous year. According to our (LP Information) latest study, the global Oncology Therapeutic Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Oncology Therapeutic Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Oncology Therapeutic Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Oncology Therapeutic Drug market, reaching US$ million by the year 2028. As for the Europe Oncology Therapeutic Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Oncology Therapeutic Drug players cover AbbVie, Amgen, Astellas Pharma, and AstraZeneca, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Therapeutic Drug market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Chemotherapy

Targeted Therapy

Immunotherapy

Hormonal Therapy

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Breast Cancer

Gastrointestinal Cancer

Prostate Cancer

Respiratory and Lung Cancer

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

AbbVie

Amgen

Astellas Pharma

AstraZeneca

Bayer

Biogen

Bristol Myers Squibb

Celgene

Eisai

Eli Lilly and Company

Gilead Sciences

Ipsen

Johnson and Johnson

Merck

Novartis

Otsuka Pharmaceutical

Pfizer

F. Hoffmann-La Roche

Sanofi

Takeda Pharmaceutical

Teva Pharmaceutical Industries

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Oncology Therapeutic Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Oncology Therapeutic Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Oncology Therapeutic Drug by Country/Region, 2017, 2022 & 2028

2.2 Oncology Therapeutic Drug Segment by Type

2.2.1 Chemotherapy

2.2.2 Targeted Therapy

2.2.3 Immunotherapy

2.2.4 Hormonal Therapy

2.2.5 Others

2.3 Oncology Therapeutic Drug Sales by Type

2.3.1 Global Oncology Therapeutic Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Oncology Therapeutic Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Oncology Therapeutic Drug Sale Price by Type (2017-2022)

2.4 Oncology Therapeutic Drug Segment by Application

2.4.1 Breast Cancer

2.4.2 Gastrointestinal Cancer

2.4.3 Prostate Cancer

2.4.4 Respiratory and Lung Cancer

2.4.5 Others

2.5 Oncology Therapeutic Drug Sales by Application

2.5.1 Global Oncology Therapeutic Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Oncology Therapeutic Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Oncology Therapeutic Drug Sale Price by Application (2017-2022)

3 Global Oncology Therapeutic Drug by Company

3.1 Global Oncology Therapeutic Drug Breakdown Data by Company

3.1.1 Global Oncology Therapeutic Drug Annual Sales by Company (2020-2022)

3.1.2 Global Oncology Therapeutic Drug Sales Market Share by Company (2020-2022)

3.2 Global Oncology Therapeutic Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Oncology Therapeutic Drug Revenue by Company (2020-2022)

3.2.2 Global Oncology Therapeutic Drug Revenue Market Share by Company (2020-2022)

3.3 Global Oncology Therapeutic Drug Sale Price by Company

3.4 Key Manufacturers Oncology Therapeutic Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Oncology Therapeutic Drug Product Location Distribution

3.4.2 Players Oncology Therapeutic Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Oncology Therapeutic Drug by Geographic Region

4.1 World Historic Oncology Therapeutic Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Oncology Therapeutic Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Oncology Therapeutic Drug Annual Revenue by Geographic Region

4.2 World Historic Oncology Therapeutic Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Oncology Therapeutic Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Oncology Therapeutic Drug Annual Revenue by Country/Region

4.3 Americas Oncology Therapeutic Drug Sales Growth

4.4 APAC Oncology Therapeutic Drug Sales Growth

4.5 Europe Oncology Therapeutic Drug Sales Growth

4.6 Middle East & Africa Oncology Therapeutic Drug Sales Growth

5 Americas

5.1 Americas Oncology Therapeutic Drug Sales by Country

5.1.1 Americas Oncology Therapeutic Drug Sales by Country (2017-2022)

5.1.2 Americas Oncology Therapeutic Drug Revenue by Country (2017-2022)

5.2 Americas Oncology Therapeutic Drug Sales by Type

5.3 Americas Oncology Therapeutic Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Oncology Therapeutic Drug Sales by Region

6.1.1 APAC Oncology Therapeutic Drug Sales by Region (2017-2022)

6.1.2 APAC Oncology Therapeutic Drug Revenue by Region (2017-2022)

6.2 APAC Oncology Therapeutic Drug Sales by Type

6.3 APAC Oncology Therapeutic Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Oncology Therapeutic Drug by Country

7.1.1 Europe Oncology Therapeutic Drug Sales by Country (2017-2022)

7.1.2 Europe Oncology Therapeutic Drug Revenue by Country (2017-2022)

7.2 Europe Oncology Therapeutic Drug Sales by Type

7.3 Europe Oncology Therapeutic Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Oncology Therapeutic Drug by Country

8.1.1 Middle East & Africa Oncology Therapeutic Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Oncology Therapeutic Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Oncology Therapeutic Drug Sales by Type

8.3 Middle East & Africa Oncology Therapeutic Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Oncology Therapeutic Drug

10.3 Manufacturing Process Analysis of Oncology Therapeutic Drug

10.4 Industry Chain Structure of Oncology Therapeutic Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Oncology Therapeutic Drug Distributors

11.3 Oncology Therapeutic Drug Customer

12 World Forecast Review for Oncology Therapeutic Drug by Geographic Region

12.1 Global Oncology Therapeutic Drug Market Size Forecast by Region

12.1.1 Global Oncology Therapeutic Drug Forecast by Region (2023-2028)

12.1.2 Global Oncology Therapeutic Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Oncology Therapeutic Drug Forecast by Type

12.7 Global Oncology Therapeutic Drug Forecast by Application

13 Key Players Analysis

13.1 AbbVie

13.1.1 AbbVie Company Information

13.1.2 AbbVie Oncology Therapeutic Drug Product Offered

13.1.3 AbbVie Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AbbVie Main Business Overview

13.1.5 AbbVie Latest Developments

13.2 Amgen

13.2.1 Amgen Company Information

13.2.2 Amgen Oncology Therapeutic Drug Product Offered

13.2.3 Amgen Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Amgen Main Business Overview

13.2.5 Amgen Latest Developments

13.3 Astellas Pharma

13.3.1 Astellas Pharma Company Information

13.3.2 Astellas Pharma Oncology Therapeutic Drug Product Offered

13.3.3 Astellas Pharma Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Astellas Pharma Main Business Overview

13.3.5 Astellas Pharma Latest Developments

13.4 AstraZeneca

13.4.1 AstraZeneca Company Information

13.4.2 AstraZeneca Oncology Therapeutic Drug Product Offered

13.4.3 AstraZeneca Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 AstraZeneca Main Business Overview

13.4.5 AstraZeneca Latest Developments

13.5 Bayer

13.5.1 Bayer Company Information

13.5.2 Bayer Oncology Therapeutic Drug Product Offered

13.5.3 Bayer Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Bayer Main Business Overview

13.5.5 Bayer Latest Developments

13.6 Biogen

13.6.1 Biogen Company Information

13.6.2 Biogen Oncology Therapeutic Drug Product Offered

13.6.3 Biogen Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Biogen Main Business Overview

13.6.5 Biogen Latest Developments

13.7 Bristol Myers Squibb

13.7.1 Bristol Myers Squibb Company Information

13.7.2 Bristol Myers Squibb Oncology Therapeutic Drug Product Offered

13.7.3 Bristol Myers Squibb Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Bristol Myers Squibb Main Business Overview

13.7.5 Bristol Myers Squibb Latest Developments

13.8 Celgene

13.8.1 Celgene Company Information

13.8.2 Celgene Oncology Therapeutic Drug Product Offered

13.8.3 Celgene Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Celgene Main Business Overview

13.8.5 Celgene Latest Developments

13.9 Eisai

13.9.1 Eisai Company Information

13.9.2 Eisai Oncology Therapeutic Drug Product Offered

13.9.3 Eisai Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Eisai Main Business Overview

13.9.5 Eisai Latest Developments

13.10 Eli Lilly and Company

13.10.1 Eli Lilly and Company Company Information

13.10.2 Eli Lilly and Company Oncology Therapeutic Drug Product Offered

13.10.3 Eli Lilly and Company Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Eli Lilly and Company Main Business Overview

13.10.5 Eli Lilly and Company Latest Developments

13.11 Gilead Sciences

13.11.1 Gilead Sciences Company Information

13.11.2 Gilead Sciences Oncology Therapeutic Drug Product Offered

13.11.3 Gilead Sciences Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Gilead Sciences Main Business Overview

13.11.5 Gilead Sciences Latest Developments

13.12 Ipsen

13.12.1 Ipsen Company Information

13.12.2 Ipsen Oncology Therapeutic Drug Product Offered

13.12.3 Ipsen Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Ipsen Main Business Overview

13.12.5 Ipsen Latest Developments

13.13 Johnson and Johnson

13.13.1 Johnson and Johnson Company Information

13.13.2 Johnson and Johnson Oncology Therapeutic Drug Product Offered

13.13.3 Johnson and Johnson Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Johnson and Johnson Main Business Overview

13.13.5 Johnson and Johnson Latest Developments

13.14 Merck

13.14.1 Merck Company Information

13.14.2 Merck Oncology Therapeutic Drug Product Offered

13.14.3 Merck Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Merck Main Business Overview

13.14.5 Merck Latest Developments

13.15 Novartis

13.15.1 Novartis Company Information

13.15.2 Novartis Oncology Therapeutic Drug Product Offered

13.15.3 Novartis Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Novartis Main Business Overview

13.15.5 Novartis Latest Developments

13.16 Otsuka Pharmaceutical

13.16.1 Otsuka Pharmaceutical Company Information

13.16.2 Otsuka Pharmaceutical Oncology Therapeutic Drug Product Offered

13.16.3 Otsuka Pharmaceutical Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Otsuka Pharmaceutical Main Business Overview

13.16.5 Otsuka Pharmaceutical Latest Developments

13.17 Pfizer

13.17.1 Pfizer Company Information

13.17.2 Pfizer Oncology Therapeutic Drug Product Offered

13.17.3 Pfizer Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Pfizer Main Business Overview

13.17.5 Pfizer Latest Developments

13.18 F. Hoffmann-La Roche

13.18.1 F. Hoffmann-La Roche Company Information

13.18.2 F. Hoffmann-La Roche Oncology Therapeutic Drug Product Offered

13.18.3 F. Hoffmann-La Roche Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 F. Hoffmann-La Roche Main Business Overview

13.18.5 F. Hoffmann-La Roche Latest Developments

13.19 Sanofi

13.19.1 Sanofi Company Information

13.19.2 Sanofi Oncology Therapeutic Drug Product Offered

13.19.3 Sanofi Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Sanofi Main Business Overview

13.19.5 Sanofi Latest Developments

13.20 Takeda Pharmaceutical

13.20.1 Takeda Pharmaceutical Company Information

13.20.2 Takeda Pharmaceutical Oncology Therapeutic Drug Product Offered

13.20.3 Takeda Pharmaceutical Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Takeda Pharmaceutical Main Business Overview

13.20.5 Takeda Pharmaceutical Latest Developments

13.21 Teva Pharmaceutical Industries

13.21.1 Teva Pharmaceutical Industries Company Information

13.21.2 Teva Pharmaceutical Industries Oncology Therapeutic Drug Product Offered

13.21.3 Teva Pharmaceutical Industries Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Teva Pharmaceutical Industries Main Business Overview

13.21.5 Teva Pharmaceutical Industries Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Oncology Therapeutic Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Oncology Therapeutic Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Chemotherapy

Table 4. Major Players of Targeted Therapy

Table 5. Major Players of Immunotherapy

Table 6. Major Players of Hormonal Therapy

Table 7. Major Players of Others

Table 8. Global Oncology Therapeutic Drug Sales by Type (2017-2022) & (K Units)

Table 9. Global Oncology Therapeutic Drug Sales Market Share by Type (2017-2022)

Table 10. Global Oncology Therapeutic Drug Revenue by Type (2017-2022) & ($ million)

Table 11. Global Oncology Therapeutic Drug Revenue Market Share by Type (2017-2022)

Table 12. Global Oncology Therapeutic Drug Sale Price by Type (2017-2022) & (US$/Unit)

Table 13. Global Oncology Therapeutic Drug Sales by Application (2017-2022) & (K Units)

Table 14. Global Oncology Therapeutic Drug Sales Market Share by Application (2017-2022)

Table 15. Global Oncology Therapeutic Drug Revenue by Application (2017-2022)

Table 16. Global Oncology Therapeutic Drug Revenue Market Share by Application (2017-2022)

Table 17. Global Oncology Therapeutic Drug Sale Price by Application (2017-2022) & (US$/Unit)

Table 18. Global Oncology Therapeutic Drug Sales by Company (2020-2022) & (K Units)

Table 19. Global Oncology Therapeutic Drug Sales Market Share by Company (2020-2022)

Table 20. Global Oncology Therapeutic Drug Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Oncology Therapeutic Drug Revenue Market Share by Company (2020-2022)

Table 22. Global Oncology Therapeutic Drug Sale Price by Company (2020-2022) & (US$/Unit)

Table 23. Key Manufacturers Oncology Therapeutic Drug Producing Area Distribution and Sales Area

Table 24. Players Oncology Therapeutic Drug Products Offered

Table 25. Oncology Therapeutic Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Oncology Therapeutic Drug Sales by Geographic Region (2017-2022) & (K Units)

Table 29. Global Oncology Therapeutic Drug Sales Market Share Geographic Region (2017-2022)

Table 30. Global Oncology Therapeutic Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Oncology Therapeutic Drug Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Oncology Therapeutic Drug Sales by Country/Region (2017-2022) & (K Units)

Table 33. Global Oncology Therapeutic Drug Sales Market Share by Country/Region (2017-2022)

Table 34. Global Oncology Therapeutic Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Oncology Therapeutic Drug Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Oncology Therapeutic Drug Sales by Country (2017-2022) & (K Units)

Table 37. Americas Oncology Therapeutic Drug Sales Market Share by Country (2017-2022)

Table 38. Americas Oncology Therapeutic Drug Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Oncology Therapeutic Drug Revenue Market Share by Country (2017-2022)

Table 40. Americas Oncology Therapeutic Drug Sales by Type (2017-2022) & (K Units)

Table 41. Americas Oncology Therapeutic Drug Sales Market Share by Type (2017-2022)

Table 42. Americas Oncology Therapeutic Drug Sales by Application (2017-2022) & (K Units)

Table 43. Americas Oncology Therapeutic Drug Sales Market Share by Application (2017-2022)

Table 44. APAC Oncology Therapeutic Drug Sales by Region (2017-2022) & (K Units)

Table 45. APAC Oncology Therapeutic Drug Sales Market Share by Region (2017-2022)

Table 46. APAC Oncology Therapeutic Drug Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Oncology Therapeutic Drug Revenue Market Share by Region (2017-2022)

Table 48. APAC Oncology Therapeutic Drug Sales by Type (2017-2022) & (K Units)

Table 49. APAC Oncology Therapeutic Drug Sales Market Share by Type (2017-2022)

Table 50. APAC Oncology Therapeutic Drug Sales by Application (2017-2022) & (K Units)

Table 51. APAC Oncology Therapeutic Drug Sales Market Share by Application (2017-2022)

Table 52. Europe Oncology Therapeutic Drug Sales by Country (2017-2022) & (K Units)

Table 53. Europe Oncology Therapeutic Drug Sales Market Share by Country (2017-2022)

Table 54. Europe Oncology Therapeutic Drug Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Oncology Therapeutic Drug Revenue Market Share by Country (2017-2022)

Table 56. Europe Oncology Therapeutic Drug Sales by Type (2017-2022) & (K Units)

Table 57. Europe Oncology Therapeutic Drug Sales Market Share by Type (2017-2022)

Table 58. Europe Oncology Therapeutic Drug Sales by Application (2017-2022) & (K Units)

Table 59. Europe Oncology Therapeutic Drug Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Oncology Therapeutic Drug Sales by Country (2017-2022) & (K Units)

Table 61. Middle East & Africa Oncology Therapeutic Drug Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Oncology Therapeutic Drug Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Oncology Therapeutic Drug Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Oncology Therapeutic Drug Sales by Type (2017-2022) & (K Units)

Table 65. Middle East & Africa Oncology Therapeutic Drug Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Oncology Therapeutic Drug Sales by Application (2017-2022) & (K Units)

Table 67. Middle East & Africa Oncology Therapeutic Drug Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Oncology Therapeutic Drug

Table 69. Key Market Challenges & Risks of Oncology Therapeutic Drug

Table 70. Key Industry Trends of Oncology Therapeutic Drug

Table 71. Oncology Therapeutic Drug Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Oncology Therapeutic Drug Distributors List

Table 74. Oncology Therapeutic Drug Customer List

Table 75. Global Oncology Therapeutic Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 76. Global Oncology Therapeutic Drug Sales Market Forecast by Region

Table 77. Global Oncology Therapeutic Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Oncology Therapeutic Drug Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Oncology Therapeutic Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 80. Americas Oncology Therapeutic Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Oncology Therapeutic Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 82. APAC Oncology Therapeutic Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Oncology Therapeutic Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Europe Oncology Therapeutic Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Oncology Therapeutic Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Middle East & Africa Oncology Therapeutic Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Oncology Therapeutic Drug Sales Forecast by Type (2023-2028) & (K Units)

Table 88. Global Oncology Therapeutic Drug Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Oncology Therapeutic Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Oncology Therapeutic Drug Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Oncology Therapeutic Drug Sales Forecast by Application (2023-2028) & (K Units)

Table 92. Global Oncology Therapeutic Drug Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Oncology Therapeutic Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Oncology Therapeutic Drug Revenue Market Share Forecast by Application (2023-2028)

Table 95. AbbVie Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors

Table 96. AbbVie Oncology Therapeutic Drug Product Offered

Table 97. AbbVie Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 98. AbbVie Main Business

Table 99. AbbVie Latest Developments

Table 100. Amgen Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors

Table 101. Amgen Oncology Therapeutic Drug Product Offered

Table 102. Amgen Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 103. Amgen Main Business

Table 104. Amgen Latest Developments

Table 105. Astellas Pharma Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors

Table 106. Astellas Pharma Oncology Therapeutic Drug Product Offered

Table 107. Astellas Pharma Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 108. Astellas Pharma Main Business

Table 109. Astellas Pharma Latest Developments

Table 110. AstraZeneca Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors

Table 111. AstraZeneca Oncology Therapeutic Drug Product Offered

Table 112. AstraZeneca Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 113. AstraZeneca Main Business

Table 114. AstraZeneca Latest Developments

Table 115. Bayer Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors

Table 116. Bayer Oncology Therapeutic Drug Product Offered

Table 117. Bayer Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 118. Bayer Main Business

Table 119. Bayer Latest Developments

Table 120. Biogen Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors

Table 121. Biogen Oncology Therapeutic Drug Product Offered

Table 122. Biogen Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 123. Biogen Main Business

Table 124. Biogen Latest Developments

Table 125. Bristol Myers Squibb Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors

Table 126. Bristol Myers Squibb Oncology Therapeutic Drug Product Offered

Table 127. Bristol Myers Squibb Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 128. Bristol Myers Squibb Main Business

Table 129. Bristol Myers Squibb Latest Developments

Table 130. Celgene Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors

Table 131. Celgene Oncology Therapeutic Drug Product Offered

Table 132. Celgene Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 133. Celgene Main Business

Table 134. Celgene Latest Developments

Table 135. Eisai Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors

Table 136. Eisai Oncology Therapeutic Drug Product Offered

Table 137. Eisai Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 138. Eisai Main Business

Table 139. Eisai Latest Developments

Table 140. Eli Lilly and Company Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors

Table 141. Eli Lilly and Company Oncology Therapeutic Drug Product Offered

Table 142. Eli Lilly and Company Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 143. Eli Lilly and Company Main Business

Table 144. Eli Lilly and Company Latest Developments

Table 145. Gilead Sciences Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors

Table 146. Gilead Sciences Oncology Therapeutic Drug Product Offered

Table 147. Gilead Sciences Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 148. Gilead Sciences Main Business

Table 149. Gilead Sciences Latest Developments

Table 150. Ipsen Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors

Table 151. Ipsen Oncology Therapeutic Drug Product Offered

Table 152. Ipsen Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 153. Ipsen Main Business

Table 154. Ipsen Latest Developments

Table 155. Johnson and Johnson Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors

Table 156. Johnson and Johnson Oncology Therapeutic Drug Product Offered

Table 157. Johnson and Johnson Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 158. Johnson and Johnson Main Business

Table 159. Johnson and Johnson Latest Developments

Table 160. Merck Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors

Table 161. Merck Oncology Therapeutic Drug Product Offered

Table 162. Merck Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 163. Merck Main Business

Table 164. Merck Latest Developments

Table 165. Novartis Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors

Table 166. Novartis Oncology Therapeutic Drug Product Offered

Table 167. Novartis Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 168. Novartis Main Business

Table 169. Novartis Latest Developments

Table 170. Otsuka Pharmaceutical Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors

Table 171. Otsuka Pharmaceutical Oncology Therapeutic Drug Product Offered

Table 172. Otsuka Pharmaceutical Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 173. Otsuka Pharmaceutical Main Business

Table 174. Otsuka Pharmaceutical Latest Developments

Table 175. Pfizer Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors

Table 176. Pfizer Oncology Therapeutic Drug Product Offered

Table 177. Pfizer Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 178. Pfizer Main Business

Table 179. Pfizer Latest Developments

Table 180. F. Hoffmann-La Roche Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors

Table 181. F. Hoffmann-La Roche Oncology Therapeutic Drug Product Offered

Table 182. F. Hoffmann-La Roche Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 183. F. Hoffmann-La Roche Main Business

Table 184. F. Hoffmann-La Roche Latest Developments

Table 185. Sanofi Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors

Table 186. Sanofi Oncology Therapeutic Drug Product Offered

Table 187. Sanofi Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 188. Sanofi Main Business

Table 189. Sanofi Latest Developments

Table 190. Takeda Pharmaceutical Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors

Table 191. Takeda Pharmaceutical Oncology Therapeutic Drug Product Offered

Table 192. Takeda Pharmaceutical Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 193. Takeda Pharmaceutical Main Business

Table 194. Takeda Pharmaceutical Latest Developments

Table 195. Teva Pharmaceutical Industries Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors

Table 196. Teva Pharmaceutical Industries Oncology Therapeutic Drug Product Offered

Table 197. Teva Pharmaceutical Industries Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 198. Teva Pharmaceutical Industries Main Business

Table 199. Teva Pharmaceutical Industries Latest Developments

List of Figures

Figure 1. Picture of Oncology Therapeutic Drug

Figure 2. Oncology Therapeutic Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Oncology Therapeutic Drug Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Oncology Therapeutic Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Oncology Therapeutic Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Chemotherapy

Figure 10. Product Picture of Targeted Therapy

Figure 11. Product Picture of Immunotherapy

Figure 12. Product Picture of Hormonal Therapy

Figure 13. Product Picture of Others

Figure 14. Global Oncology Therapeutic Drug Sales Market Share by Type in 2021

Figure 15. Global Oncology Therapeutic Drug Revenue Market Share by Type (2017-2022)

Figure 16. Oncology Therapeutic Drug Consumed in Breast Cancer

Figure 17. Global Oncology Therapeutic Drug Market: Breast Cancer (2017-2022) & (K Units)

Figure 18. Oncology Therapeutic Drug Consumed in Gastrointestinal Cancer

Figure 19. Global Oncology Therapeutic Drug Market: Gastrointestinal Cancer (2017-2022) & (K Units)

Figure 20. Oncology Therapeutic Drug Consumed in Prostate Cancer

Figure 21. Global Oncology Therapeutic Drug Market: Prostate Cancer (2017-2022) & (K Units)

Figure 22. Oncology Therapeutic Drug Consumed in Respiratory and Lung Cancer

Figure 23. Global Oncology Therapeutic Drug Market: Respiratory and Lung Cancer (2017-2022) & (K Units)

Figure 24. Oncology Therapeutic Drug Consumed in Others

Figure 25. Global Oncology Therapeutic Drug Market: Others (2017-2022) & (K Units)

Figure 26. Global Oncology Therapeutic Drug Sales Market Share by Application (2017-2022)

Figure 27. Global Oncology Therapeutic Drug Revenue Market Share by Application in 2021

Figure 28. Oncology Therapeutic Drug Revenue Market by Company in 2021 ($ Million)

Figure 29. Global Oncology Therapeutic Drug Revenue Market Share by Company in 2021

Figure 30. Global Oncology Therapeutic Drug Sales Market Share by Geographic Region (2017-2022)

Figure 31. Global Oncology Therapeutic Drug Revenue Market Share by Geographic Region in 2021

Figure 32. Global Oncology Therapeutic Drug Sales Market Share by Region (2017-2022)

Figure 33. Global Oncology Therapeutic Drug Revenue Market Share by Country/Region in 2021

Figure 34. Americas Oncology Therapeutic Drug Sales 2017-2022 (K Units)

Figure 35. Americas Oncology Therapeutic Drug Revenue 2017-2022 ($ Millions)

Figure 36. APAC Oncology Therapeutic Drug Sales 2017-2022 (K Units)

Figure 37. APAC Oncology Therapeutic Drug Revenue 2017-2022 ($ Millions)

Figure 38. Europe Oncology Therapeutic Drug Sales 2017-2022 (K Units)

Figure 39. Europe Oncology Therapeutic Drug Revenue 2017-2022 ($ Millions)

Figure 40. Middle East & Africa Oncology Therapeutic Drug Sales 2017-2022 (K Units)

Figure 41. Middle East & Africa Oncology Therapeutic Drug Revenue 2017-2022 ($ Millions)

Figure 42. Americas Oncology Therapeutic Drug Sales Market Share by Country in 2021

Figure 43. Americas Oncology Therapeutic Drug Revenue Market Share by Country in 2021

Figure 44. United States Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 45. Canada Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 46. Mexico Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. Brazil Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. APAC Oncology Therapeutic Drug Sales Market Share by Region in 2021

Figure 49. APAC Oncology Therapeutic Drug Revenue Market Share by Regions in 2021

Figure 50. China Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. Japan Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. South Korea Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 53. Southeast Asia Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. India Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. Australia Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. Europe Oncology Therapeutic Drug Sales Market Share by Country in 2021

Figure 57. Europe Oncology Therapeutic Drug Revenue Market Share by Country in 2021

Figure 58. Germany Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. France Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 60. UK Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 61. Italy Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. Russia Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. Middle East & Africa Oncology Therapeutic Drug Sales Market Share by Country in 2021

Figure 64. Middle East & Africa Oncology Therapeutic Drug Revenue Market Share by Country in 2021

Figure 65. Egypt Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 66. South Africa Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 67. Israel Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 68. Turkey Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 69. GCC Country Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 70. Manufacturing Cost Structure Analysis of Oncology Therapeutic Drug in 2021

Figure 71. Manufacturing Process Analysis of Oncology Therapeutic Drug

Figure 72. Industry Chain Structure of Oncology Therapeutic Drug

Figure 73. Channels of Distribution

Figure 74. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390